Micron Stock And 2 Fast Growth Picks With Major Catalysts Ahead - simplywall.st

This article analyzes Micron Technology and two other high-growth companies—SELLAS Life Sciences Group and ARS Pharmaceuticals. Micron, a global semiconductor leader, plays a central role in AI hardwa... Read original →

Micron’s valuation discount reflects deeper concerns about its technology gap, not just AI demand cyclicality. A 3–6 month delay in HBM4 ramp versus Samsung would erode its leverage in NVIDIA’s GB200 supply chain, accelerating hyperscaler adoption of CXL-based memory disaggregation to reduce vendor lock-in. While U.S. CHIPS Act subsidies ease capex burdens, persistent export controls are inflating compliance costs across its packaging hubs in Taiwan, China and Japan. Critically, if TSV stacking yields don’t exceed 85% by 2027, Micron may be forced into deep CoWoS co-development with SK Hynix—sacrificing architectural sovereignty. The next 18 months will pivot from “AI memory shortage” to “structural oversupply,” where only firms mastering hybrid bonding and thermal management will survive.